Skip to main content

Table 2 Measurement Scheme

From: (Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial

Variable

Instrument

T-1

T0

T1

T2

T3

T4

Effect evaluation: primary outcomes

Depressive & anxiety disorders

MINI

X

 

X

X

X

X

Severity depression

CES-D, GDS-5

 

X

 

X

 

X

Severity anxiety

HADS anxiety subscale

 

X

 

X

 

X

Effect evaluation: secondary outcomes

Quality of life caregiver

SF-12

 

X

 

X

 

X

Caregiver burden

SSCQ, CRA, SRB

 

X

 

X

 

X

Social support in caregiver

Questions based on assessment battery study

 

X

 

X

 

X

Days until institutionalisation patient

according to carer

Continuous registration

Economic evaluation

Direct and indirect costs carer + patient

Cost diaries

 

X

 

X

 

X

  1. T0 = baseline
  2. T1 = 3 months after baseline
  3. T2 = 6 months after baseline
  4. T3 = 9 months after baseline
  5. T4 = 12 months after baseline